Editors' ChoiceNeuroscience

Neurons Get the Neuroligin-1 Advantage

See allHide authors and affiliations

Science Signaling  18 Dec 2012:
Vol. 5, Issue 255, pp. ec328
DOI: 10.1126/scisignal.2003886

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

  • Misspelling in the Title

    The Editors wish to notify the readers that the title of this Editors' Choice had an error: Neuroligin-1 was misspelled as Neurolignin-1. The title has been updated as of 28 December 2013. The protein was properly spelled in the body of the summary.

    Competing Interests: None declared.

Stay Connected to Science Signaling